Key Development In Thanh Hoa Province, the Ministry of Health (MOH) of Vietnam inaugurated its 2026 Professional Training Conference on... Read more
Category: Uncategorized
Accelerating National Healthcare Digital Transformation: Ministry of Health Expands Electronic Medical Records (EMR) Across 1,263 Hospitals and Integrates Over 34 Million Electronic Health Records on VNeID
Key Development On the afternoon of August 24, 2026, Assoc. Prof. Nguyen Tri Thuc, MD, PhD – Vice Minister of... Read more
Urban Primary Healthcare Reform: Ho Chi Minh City Department of Health Proposes 3-to-5-Year Secondment of Hospital Physicians as Community Health Station Directors to Anchor Multi-Tiered Healthcare Integration
Key Development On August 24, 2026, Assoc. Prof. Tang Chi Thuong, MD, PhD—Director of the Ho Chi Minh City Department... Read more
ASTRAZENECA VIETNAM’S LOGISTICS TRANSITION SIGNALS A BROADER PHARMA SHIFT
Key Development On August 22, 2026, Vietnam’s Ministry of Health issued Decision No. 2684/QĐ-BYT withdrawing AstraZeneca Vietnam’s pharmaceutical business eligibility... Read more
Biologics & ADC CDMO Consolidation: Piramal Pharma Acquires Controlling 74% Stake in Yapan Bio for $7.95 Million – Accelerating Integrated ADCelerate™ Bioconjugation Platform
Key Development Global biopharmaceutical enterprise Piramal Pharma Limited (PPL, NSE: PPLPHARMA / BSE: 543635) has formally completed the acquisition of... Read more
European CDMO Infrastructure Expansion: SK pharmteco Completes Major Manufacturing Expansions in Swords, Ireland – Boosting Small-Molecule API, High-Potency API (HPAPI), and ADC Payload Capabilities
Key Development Global contract development and manufacturing organization (CDMO) SK pharmteco (a subsidiary of South Korea's SK Group) has officially... Read more
AI-Driven Biologics Engineering: Bristol Myers Squibb and Chai Discovery Partner to Accelerate De Novo Therapeutic Antibody Candidate Identification
Key Development Global biopharmaceutical major Bristol Myers Squibb (NYSE: BMY) has entered into a strategic discovery collaboration with biological AI... Read more
Advanced Biologics Testing & CMC Validation: Charles River Laboratories and Medigen Partner to Validate Virus Seed Bank for Next-Generation Multivalent Enterovirus Vaccine
Key Development Global non-clinical research and biologics testing provider Charles River Laboratories International, Inc. (NYSE: CRL) and Taiwan-based vaccine developer... Read more
Mass Tort Litigation Defense: Abbott Agrees to $670 Million Settlement to Resolve 2,000 Preterm Infant Formula Necrotizing Enterocolitis (NEC) Claims
Key Development Global healthcare and medical nutrition leader Abbott Laboratories (NYSE: ABT) announced on August 20, 2026, that it has... Read more









